Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bety Ciobanu"'
Autor:
Barbara Yim, Anne Navaleza, Rose Catchatourian, Moushmi Shah, Margaret Telfer, Paul G. Rubinstein, Augustin Haidau, Manila Gaddh, Shylendra B Sreenivasappa, Tareq Braik, Mohammed A. Kassem, Bety Ciobanu
Publikováno v:
Blood. 116:1779-1779
Abstract 1779 Introduction: Tumor Lysis Syndrome (TLS) is an oncologic emergency that leads to a host of metabolic disturbances which can ultimately result in acute renal failure and death. Currently rasburicase, Elitek™, is FDA approved for the tr
Publikováno v:
Blood. 114:4757-4757
Abstract 4757 Background The response of patients with relapse/refractory (s/p CHOPR) Diffuse large B Cell Lymphoma (DLBCL) to RICE chemotherapy in transplant ineligible patients (pts) is not well studied. Methods 28 consecutive pts with DLBCL, relap
Publikováno v:
Blood. 114:4791-4791
Abstract 4791 Background Response and factors affecting response in patients with aggressive Non Hodgkin's Gastro Intestinal (GI) tract lymphoma to upfront Rituximab based chemotherapy is not well characterized. Methods 41 consecutive pts diagnosed a
Autor:
Mousami Shah, Michael Russell Mullane, Bety Ciobanu, Barbara Yim, Shylendra B Sreenivasappa, Rafid Kouz
Publikováno v:
Journal of Clinical Oncology. 27:e16164-e16164
e16164 Background: Sunitinib is a tyrosine kinase inhibitor active in renal cell cancer (RCC). There is scanty literature of its efficacy in minority population. Methods: 21 patients (pts) with RCC who received sunitinib between February 2006-Septemb
Autor:
Bety Ciobanu, Thomas E. Lad, Shylendra B Sreenivasappa, Samuel Ofori, Lily Hussein, Mousami Shah, K. Adab, Mohammed A. Kassem, Rafid Kouz
Publikováno v:
Journal of Clinical Oncology. 27:7558-7558
7558 Background: Lung cancer is the leading cause of cancer death. Response and survival of patients (pts) with stage III lung cancer in minority population is not well studied. Methods: 79 pts treated between 2001 and 2006 were studied as a retrospe
Autor:
Bety Ciobanu, Rose Catchatourian, Margaret Clare Telfer, Decebal S. Griza, Paula Kovarik, Rafid Kouz, Sunita Nathan, Samuel Ofori-Ntow, Thomas E. Lad
Publikováno v:
Blood. 110:4444-4444
Background: The phenotypic expression of Hodgkin lymphoma among different ethnic groups is not well described. We conducted a study to look at the characteristics and the clinical response of Hodgkin lymphoma patients of different ethnicities to stan
Autor:
Margaret Clare Telfer, Ahmad Jajeh, Bety Ciobanu, Sunita Nathan, Paula Kovarik, Rafid Kouz, Decebal S. Griza, Samuel Ofori-Ntow, Rose Catchatourian
Publikováno v:
Journal of Clinical Oncology. 25:18510-18510
18510 Background: There is scant literature on the characteristics of Hodgkin’s disease in Hispanics. We studied the characteristics of this disease in Hispanics compared to other ethnic-racial groups in our large multiethnic Hodgkin’s disease ca